FDA Notes Medtronic CardioVascular Device Deaths

WASHINGTON -- The Food and Drug Administration said it saw a higher death rate after five years among patients treated for abdominal aortic aneurysms with a Medtronic Inc. device than among those treated through conventional surgery.